Lanzamiento Enero 2027

Estudio2014Acceso abierto

Olive oil in the prevention and treatment of osteoporosis after artificial menopause

Liu H, Huang H, Li B, Wu D, Wang F, Zheng Xh, Chen Q, Wu B, Fan X

Clinical interventions in aging · 35 citas

Cómo se estudió

Diseño
Estudio en animales (clasificado por nuestro filtro de IA)
Estudiado en
Personas, más trabajo en animales o laboratorio
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente

Según la declaración de financiación del texto completo.

Publicación

Publicado
2014-12-01 · Clin Interv Aging · vol. 9 · pág. 2087
Editorial
Dove Medical Press
Citado
43 citas · más que el 70% de estudios similares · 0.8× el promedio de su campo
Referencias
43 trabajos
Acceso
Acceso abierto (revista) · CC-BY-NC
Áreas de investigación
Edible Oils Quality and Analysis · Menopause: Health Impacts and Treatments · Fatty Acid Research and Health
Palabras clave
Medicine, Menopause, Osteoporosis, Internal medicine, Intensive care medicine
MeSH
animals, humans, rats, rats, sprague-dawley, osteoporosis, postmenopausal, nitrates, calcium, phosphorus, malondialdehyde, plant oils, alpha-fetoproteins, carcinoembryonic antigen, anti-inflammatory agents, antigens, tumor-associated, carbohydrate, interleukin-6, estrogens, antioxidants, absorptiometry, photon, bone density, female, olive oil

9 autores

  • Huilan Liu🇨🇳Xiamen University
  • Huijuan Huang🇨🇳Xiamen University
  • Baoheng Li🇨🇳Xiamen University
  • Wu Dong🇨🇳Xiamen University
  • Fengmei Wang🇨🇳Xiamen University
  • Xiaohua Zheng🇨🇳Xiamen University
  • Qingxia Chen🇨🇳Xiamen University
  • Bifang Wu🇨🇳Xiamen University
  • Xiaojie Fan🇨🇳Xiamen University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

The goal of this study was to investigate the anti-osteoporosis effect of extra virgin olive oil (EVOO) in vivo, and explore its antioxidant, anti-inflammatory properties in Sprague Dawley rats and its anticancer properties in patients.

Materials and methods

A total of 120 healthy female Sprague Dawley rats aged 6 months were divided into four groups: 1) sham-operated control (Sham group, n=30); 2) ovariectomized (OVX group, n=30); 3) ovariectomized rats supplemented with EVOO (OVX + Olive, n=30); 4) ovariectomized rats supplemented with estrogen (OVX + E2, n=30). EVOO and estrogen were administered by oral gavage at a dose of 1 mL/100 g weight on a daily basis for 12 consecutive weeks. Twelve weeks later blood samples were obtained to detect the levels of calcium, alkaline phosphatase, phosphorus, interleukin-6 (IL-6), malonyldialdehyde (MDA), and nitrate content. Dual energy X-ray absorptiometer measured bone mineral density (BMD) of ovariectomized Sprague Dawley rats that had been fed olive oil for 3 months. Blood samples from patients, who regularly consumed olive oil over a 1 year period were also used to measure carbohydrate antigen 125, carcino-embryonic antigen, α-fetoprotein, and carbohydrate antigen 19-9 levels. BMD of lumbar spine and left femur was also evaluated by dual energy X-ray absorptiometry.

Results

Animal experiments showed that EVOO significantly increased BMD and decreased phosphatase, alkaline phosphatase, IL-6, MDA, and nitrate levels. However, it had no significant effect on the Ca(2+) level. In clinical follow-up, EVOO also improved patient BMD levels on L3, L4, and left femoral neck, and reduced carbohydrate antigen 125, α-fetoprotein, and carcino-embryonic antigen levels. But it had no significant effect on the carbohydrate antigen 19-9 level.

Conclusion

EVOO illustrated significant anti-osteoporosis, antioxidant, anti-inflammatory, and anticancer properties in vivo. However, further studies are required to determine the active component(s) responsible for these effects.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.